Human AKR1C3 binds agonists of GPR84 and participates in an expanded polyamine pathway.

Natavan Dudkina, Hyun Bong Park, Deguang Song, Abhishek Jain, Sajid A Khan, Richard A Flavell, Caroline H Johnson, Noah W Palm, Jason M Crawford
Author Information
  1. Natavan Dudkina: Department of Chemistry, Yale University, New Haven, CT 06520, USA; Institute of Biomolecular Design & Discovery, Yale University, West Haven, CT 06516, USA.
  2. Hyun Bong Park: Department of Chemistry, Yale University, New Haven, CT 06520, USA; Institute of Biomolecular Design & Discovery, Yale University, West Haven, CT 06516, USA; Department of Biology, College of Natural Sciences, Gangneung-Wonju National University, Gangneung 25457, Republic of Korea.
  3. Deguang Song: Department of Immunobiology, Yale School of Medicine, New Haven, CT 06536, USA.
  4. Abhishek Jain: Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT 06536, USA.
  5. Sajid A Khan: Department of Surgery, Division of Surgical Oncology, Yale School of Medicine, New Haven, CT 06510, USA.
  6. Richard A Flavell: Department of Immunobiology, Yale School of Medicine, New Haven, CT 06536, USA; Howard Hughes Medical Institute, Yale School of Medicine, New Haven, CT 06536, USA.
  7. Caroline H Johnson: Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT 06536, USA. Electronic address: caroline.johnson@yale.edu.
  8. Noah W Palm: Department of Immunobiology, Yale School of Medicine, New Haven, CT 06536, USA. Electronic address: noah.palm@yale.edu.
  9. Jason M Crawford: Department of Chemistry, Yale University, New Haven, CT 06520, USA; Institute of Biomolecular Design & Discovery, Yale University, West Haven, CT 06516, USA; Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, CT 06536, USA. Electronic address: jason.crawford@yale.edu.

Abstract

Altered human aldo-keto reductase family 1 member C3 (AKR1C3) expression has been associated with poor prognosis in diverse cancers, ferroptosis resistance, and metabolic diseases. Despite its clinical significance, the endogenous biochemical roles of AKR1C3 remain incompletely defined. Using untargeted metabolomics, we identified a major transformation mediated by AKR1C3, in which a spermine oxidation product "sperminal" is reduced to "sperminol." Sperminal causes DNA damage and activates the DNA double-strand break response, whereas sperminol induces autophagy in vitro. AKR1C3 also pulls down acyl-pyrones and pyrone-211 inhibits AKR1C3 activity. Through G protein-coupled receptor ligand screening, we determined that pyrone-211 is also a potent agonist of the semi-orphan receptor GPR84. Strikingly, mammalian fatty acid synthase produces acyl-pyrones in vitro, and this production is modulated by NADPH. Taken together, our studies support a regulatory role of AKR1C3 in an expanded polyamine pathway and a model linking fatty acid synthesis and NADPH levels to GPR84 signaling.

Keywords

References

  1. Nat Commun. 2023 Jun 6;14(1):3271 [PMID: 37277332]
  2. Sci Rep. 2020 Mar 17;10(1):4905 [PMID: 32184446]
  3. Chem Biol Interact. 2015 Jun 5;234:236-46 [PMID: 25304492]
  4. PLoS Biol. 2005 May;3(5):e156 [PMID: 15884975]
  5. Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11140-5 [PMID: 9736703]
  6. Indian J Pharmacol. 2008 Jun;40(3):121-5 [PMID: 20040939]
  7. Biochemistry. 1998 Mar 10;37(10):3538-48 [PMID: 9521675]
  8. Amino Acids. 2014 Mar;46(3):511-9 [PMID: 23771789]
  9. Br J Cancer. 2016 Dec 6;115(12):1530-1539 [PMID: 27824809]
  10. Nature. 2021 Sep;597(7877):549-554 [PMID: 34497417]
  11. Chembiochem. 2022 Nov 4;23(21):e202200431 [PMID: 35997218]
  12. Cell. 2019 May 16;177(5):1217-1231.e18 [PMID: 31006530]
  13. Science. 2022 Oct 28;378(6618):eabm3233 [PMID: 36302024]
  14. Cancer Res. 2006 Dec 1;66(23):11471-7 [PMID: 17145895]
  15. Beilstein J Org Chem. 2016 Mar 24;12:571-88 [PMID: 27340449]
  16. Toxicol Lett. 2008 Sep;181(1):1-6 [PMID: 18616992]
  17. Eur J Pharmacol. 2020 Jun 15;877:173090 [PMID: 32234529]
  18. J Biol Chem. 1968 Oct 25;243(20):5471-8 [PMID: 4302787]
  19. Nat Prod Rep. 2007 Oct;24(5):1041-72 [PMID: 17898897]
  20. Am J Pathol. 2018 May;188(5):1132-1148 [PMID: 29454750]
  21. Nat Rev Mol Cell Biol. 2016 Jul;17(7):451-9 [PMID: 26979502]
  22. Drug Metab Rev. 2008;40(4):553-624 [PMID: 18949601]
  23. Carcinogenesis. 2009 Sep;30(9):1571-80 [PMID: 19608619]
  24. BMC Cancer. 2010 Dec 06;10:672 [PMID: 21134280]
  25. Can J Physiol Pharmacol. 1987 Oct;65(10):2024-35 [PMID: 3322538]
  26. Oncol Lett. 2019 Nov;18(5):4515-4522 [PMID: 31611960]
  27. Med Sci (Basel). 2018 Mar 08;6(1): [PMID: 29517999]
  28. Ther Drug Monit. 2005 Dec;27(6):747-51 [PMID: 16404815]
  29. Cancer Lett. 2023 Oct 10;574:216384 [PMID: 37716465]
  30. Cell Death Differ. 2015 Mar;22(3):509-16 [PMID: 25526088]
  31. J Biol Chem. 1964 Jul;239:2194-203 [PMID: 14209948]
  32. J Med Chem. 2020 Mar 12;63(5):2391-2410 [PMID: 31721581]
  33. Nat Rev Drug Discov. 2020 Jun;19(6):374 [PMID: 32494048]
  34. Breast Cancer Res Treat. 2012 Feb;132(1):175-87 [PMID: 21597922]
  35. J Am Chem Soc. 2014 Jul 2;136(26):9244-7 [PMID: 24932672]
  36. Eur J Biochem. 1969 Apr;8(4):495-502 [PMID: 4389576]
  37. Arch Biochem Biophys. 2007 Aug 15;464(2):241-50 [PMID: 17537398]
  38. J Biol Chem. 2001 Jan 26;276(4):2890-7 [PMID: 11060293]
  39. DNA Cell Biol. 2020 Nov;39(11):1926-1937 [PMID: 33001759]
  40. Trends Immunol. 2020 Nov;41(11):1037-1050 [PMID: 33055013]
  41. Cancer Res. 2021 Mar 1;81(5):1361-1374 [PMID: 33361392]
  42. Nat Rev Drug Discov. 2007 May;6(5):373-90 [PMID: 17464296]
  43. Sci Rep. 2023 Feb 25;13(1):3280 [PMID: 36841845]
  44. Bioorg Med Chem Lett. 2015 Mar 15;25(6):1244-8 [PMID: 25677663]
  45. Nat Commun. 2021 Apr 8;12(1):2105 [PMID: 33833232]
  46. Amino Acids. 2007 Aug;33(2):231-40 [PMID: 17396215]
  47. Nat Rev Microbiol. 2016 Aug 11;14(9):576-88 [PMID: 27510864]
  48. Front Pharmacol. 2017 Mar 14;8:119 [PMID: 28352233]
  49. Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):64-9 [PMID: 18165312]
  50. J Biol Chem. 2008 Sep 5;283(36):24584-93 [PMID: 18591242]
  51. PLoS One. 2018 Jun 19;13(6):e0199122 [PMID: 29920533]
  52. Toxicol Appl Pharmacol. 2014 Aug 1;278(3):238-48 [PMID: 24832494]
  53. Cell Mol Life Sci. 2019 Oct;76(20):3987-4008 [PMID: 31227845]
  54. Angew Chem Int Ed Engl. 2022 Aug 22;61(34):e202206851 [PMID: 35726672]
  55. Nat Rev Cancer. 2018 Nov;18(11):681-695 [PMID: 30181570]
  56. Pharmacol Res. 2018 May;131:185-198 [PMID: 29471103]
  57. Hum Genomics. 2009 Jul;3(4):362-70 [PMID: 19706366]
  58. J Med Chem. 2020 Oct 22;63(20):11305-11329 [PMID: 32463235]
  59. Br J Cancer. 2023 Aug;129(2):266-274 [PMID: 37173365]
  60. Brain Behav Immun. 2015 May;46:112-20 [PMID: 25637481]
  61. Biochem J. 2000 Oct 1;351(Pt 1):67-77 [PMID: 10998348]
  62. Nat Struct Mol Biol. 2015 May;22(5):362-9 [PMID: 25895059]
  63. Front Immunol. 2018 Jun 20;9:1419 [PMID: 29973940]
  64. J Biol Chem. 2018 Nov 30;293(48):18693-18701 [PMID: 30254075]
  65. Nucleic Acids Res. 2007 Jan;35(Database issue):D521-6 [PMID: 17202168]
  66. Science. 2008 Sep 5;321(5894):1315-22 [PMID: 18772430]
  67. J Biol Chem. 2013 Apr 12;288(15):10684-91 [PMID: 23449982]
  68. Chem Pharm Bull (Tokyo). 2000 Oct;48(10):1570-6 [PMID: 11045471]
  69. Nucleic Acids Res. 2009 Jan;37(Database issue):D603-10 [PMID: 18953024]
  70. Biochem J. 2009 Jul 15;421(3):323-38 [PMID: 19589128]
  71. Nat Chem Biol. 2021 Apr;17(4):363-368 [PMID: 33589842]
  72. Chem Biol Interact. 2013 Feb 25;202(1-3):234-42 [PMID: 23165153]
  73. Cancer Lett. 2021 Oct 28;519:91-104 [PMID: 34186159]
  74. Nat Rev Microbiol. 2022 Mar;20(3):143-160 [PMID: 34552265]
  75. ACS Med Chem Lett. 2016 Mar 30;7(6):579-83 [PMID: 27326330]
  76. J Biol Chem. 2016 Jul 15;291(29):14904-12 [PMID: 27268251]
  77. ACS Chem Biol. 2019 Sep 20;14(9):2055-2064 [PMID: 31465201]
  78. ACS Chem Biol. 2018 Dec 21;13(12):3286-3293 [PMID: 30403848]
  79. Anal Chem. 2012 Jun 5;84(11):5035-9 [PMID: 22533540]
  80. Nat Biotechnol. 2016 Aug 9;34(8):828-837 [PMID: 27504778]
  81. Ann N Y Acad Sci. 2009 Feb;1155:33-42 [PMID: 19250190]
  82. Cancer Cell Int. 2020 Nov 5;20(1):539 [PMID: 33292222]
  83. PLoS One. 2014 Nov 24;9(11):e111911 [PMID: 25419901]
  84. J Biol Chem. 2002 Jul 5;277(27):24799-808 [PMID: 11978787]
  85. Acta Pharmacol Sin. 2022 Aug;43(8):2042-2054 [PMID: 34912006]
  86. Science. 2001 Mar 2;291(5509):1790-2 [PMID: 11230695]
  87. J Biol Chem. 2008 Feb 15;283(7):4241-51 [PMID: 18089555]
  88. J Neurosci. 2015 Jun 10;35(23):8959-69 [PMID: 26063927]
  89. Annu Rev Anal Chem (Palo Alto Calif). 2021 Jun 5;14(1):467-487 [PMID: 34314226]
  90. PLoS One. 2016 Mar 07;11(3):e0150219 [PMID: 26950072]
  91. J Biol Chem. 2020 Jul 3;295(27):9061-9068 [PMID: 32430398]
  92. J Invest Dermatol. 2012 Apr;132(4):1103-10 [PMID: 22170488]
  93. Microbiol Rev. 1985 Mar;49(1):81-99 [PMID: 3157043]
  94. Br J Cancer. 2014 Mar 18;110(6):1506-16 [PMID: 24569460]
  95. Science. 2018 Jan 26;359(6374): [PMID: 29371440]
  96. Chem Commun (Camb). 2004 Feb 21;(4):353-9 [PMID: 14765207]
  97. J Biol Chem. 1998 Dec 25;273(52):34949-53 [PMID: 9857025]
  98. Nat Chem Biol. 2013 Sep;9(9):573-8 [PMID: 23851573]
  99. Biochemistry. 1997 Dec 23;36(51):16338-44 [PMID: 9405069]
  100. Biochim Biophys Acta. 1971 Jan 1;228(1):223-34 [PMID: 5546564]
  101. Nat Cell Biol. 2009 Nov;11(11):1305-14 [PMID: 19801973]
  102. Chem Res Toxicol. 2013 Dec 16;26(12):1782-800 [PMID: 24224555]
  103. Mol Carcinog. 2023 Jun;62(6):833-844 [PMID: 36920042]
  104. Chembiochem. 2022 Nov 18;23(22):e202200490 [PMID: 36112057]
  105. J Biol Chem. 2006 Nov 10;281(45):34457-64 [PMID: 16966319]
  106. Amino Acids. 2020 Feb;52(2):151-160 [PMID: 31016375]
  107. J Chem Inf Model. 2013 May 24;53(5):1223-8 [PMID: 23480664]
  108. Nat Chem Biol. 2024 Jul;20(7):812-822 [PMID: 38167917]
  109. J Biol Chem. 2004 Mar 12;279(11):10784-95 [PMID: 14672942]
  110. Mol Cancer. 2009 Dec 14;8:121 [PMID: 20003443]
  111. Clin Exp Med. 2015 Aug;15(3):333-41 [PMID: 24934327]
  112. Cancer Res. 1999 Feb 1;59(3):607-14 [PMID: 9973208]
  113. Angew Chem Int Ed Engl. 2018 Sep 3;57(36):11683-11687 [PMID: 29999220]
  114. Mol Cell Endocrinol. 2019 Jun 1;489:82-91 [PMID: 30012349]
  115. Cells. 2022 Mar 05;11(5): [PMID: 35269518]
  116. J Med Chem. 2020 Dec 24;63(24):15399-15409 [PMID: 33267584]
  117. Chem Res Toxicol. 2017 Jan 17;30(1):162-176 [PMID: 27806574]
  118. Biochemistry. 2004 Mar 2;43(8):2188-98 [PMID: 14979715]
  119. Protein Sci. 2019 Feb;28(2):414-428 [PMID: 30394635]
  120. Electrophoresis. 2013 Oct;34(19):2762-75 [PMID: 23436493]
  121. Arch Gen Psychiatry. 2006 Jul;63(7):824-30 [PMID: 16818872]
  122. J Cell Biol. 2011 Feb 21;192(4):615-29 [PMID: 21339330]
  123. J Biol Chem. 2018 Nov 30;293(48):18736-18745 [PMID: 30333229]
  124. J Biol Chem. 1992 Mar 5;267(7):4364-9 [PMID: 1537826]
  125. Expert Opin Drug Metab Toxicol. 2017 Oct;13(10):1063-1073 [PMID: 28871815]
  126. Nucleic Acids Res. 2021 Jul 2;49(W1):W29-W35 [PMID: 33978755]
  127. Aging Dis. 2021 Dec 1;12(8):1948-1963 [PMID: 34881079]
  128. Cell. 2023 Jul 6;186(14):3095-3110.e19 [PMID: 37321219]

Grants

  1. RM1 GM141649/NIGMS NIH HHS
  2. UL1 TR001863/NCATS NIH HHS

MeSH Term

Humans
Receptors, G-Protein-Coupled
Aldo-Keto Reductase Family 1 Member C3
Polyamines
Pyrones
HEK293 Cells

Chemicals

Receptors, G-Protein-Coupled
Aldo-Keto Reductase Family 1 Member C3
AKR1C3 protein, human
Polyamines
Pyrones

Word Cloud

Created with Highcharts 10.0.0AKR1C3GPR84fattyacidmetabolomicsDNAautophagyin vitroalsoacyl-pyronespyrone-211receptorsynthaseNADPHexpandedpolyaminepathwayAlteredhumanaldo-ketoreductasefamily1memberC3expressionassociatedpoorprognosisdiversecancersferroptosisresistancemetabolicdiseasesDespiteclinicalsignificanceendogenousbiochemicalrolesremainincompletelydefinedUsinguntargetedidentifiedmajortransformationmediatedspermineoxidationproduct"sperminal"reduced"sperminol"Sperminalcausesdamageactivatesdouble-strandbreakresponsewhereassperminolinducespullsinhibitsactivityGprotein-coupledligandscreeningdeterminedpotentagonistsemi-orphanStrikinglymammalianproducesproductionmodulatedTakentogetherstudiessupportregulatoryrolemodellinkingsynthesislevelssignalingHumanbindsagonistsparticipatescancergenotoxicityoxidativestresspolyaminesreactivecarbonylspecies

Similar Articles

Cited By